IMMUNEBIOTECH
LIVE

Serial Number

79387858

Owner

ImmuneBiotech Medical Sweden AB

Attorney

Bradley D. Crose

Filing Date

Oct 6, 2023

Add to watchlist:

No watchlists yet
View on USPTO

IMMUNEBIOTECH Trademark

Serial Number: 79387858 • Registration: 7708982

IMMUNEBIOTECH is a trademark filed by ImmuneBiotech Medical Sweden AB on October 6, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

ImmuneBiotech Medical Sweden AB (3 trademarks)

Scheelevägen 2

Entity Type: 99

Trademark Details

Filing Date

October 6, 2023

Registration Date

March 4, 2025

Published for Opposition

January 14, 2025

Goods & Services

Probiotic bacterial formulations for medical use; probiotic supplements; food supplements; bacteriological preparations for medical purposes; probiotic preparations for medical use to help maintain a natural balance of the flora of the digestive system; pharmaceutical preparations treating and preventing conditions associated with gastrointestinal disorders; dietic preparations adapted for medical and pharmaceutical purposes, namely, probiotic bacterial and bacterial cultures

Bacteriological preparations, other than for medical and veterinary use; ferments for industrial purposes, probiotic bacteria for use in the manufacture of food supplements

Business management; business administration; providing office functions; sales promotion; procurement, namely, purchasing promotional keychains, pens, cups for others; market research and market analysis; business and business organisational consultancy; business administration consultancy; advertising; providing on-line consumer information concerning health, bacteriological preparations, pharmaceutical preparations, immunology, probiotics; systemization of information into computer databases; retail store services featuring bacteriological preparations and pharmaceutical preparations

Product research and development services; biochemical research and development; research and development services in the field of bacteriology; pharmaceutical research and development, providing of information and data relating to medical research and development

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Oct 10, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 19, 2025 FICS
FINAL DISPOSITION PROCESSED
Sep 18, 2025 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jul 11, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 24, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 24, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 4, 2025 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 4, 2025 R.PR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Mar 4, 2025 NRCC
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 14, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jan 14, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 8, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 19, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 18, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 18, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 18, 2024 TROA
REFUSAL PROCESSED BY IB
Jul 15, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 26, 2024 RFCS
REFUSAL PROCESSED BY MPU
Jun 26, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 14, 2024 RFCR
NON-FINAL ACTION WRITTEN
Jun 4, 2024 CNRT
ASSIGNED TO EXAMINER
May 27, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 30, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 26, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 25, 2024 REPR